Lingotto Investment Management’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.1M	Buy	5,881,738 +950,681	+19%	+$3.67M	0.36%	25
2025 Q4	$20.2M	Buy	4,931,057 +1,255,980	+34%	+$6.22M	0.36%	26
2025 Q3	$17.9M	Hold	3,675,077	–	–	0.34%	25
2025 Q2	$18.6M	Hold	3,675,077	–	–	0.4%	23
2025 Q1	$19.4M	Hold	3,675,077	–	–	0.51%	22
2024 Q4	$24.8M	Hold	3,675,077	–	–	0.67%	21
2024 Q3	$24.2M	Hold	3,675,077	–	–	0.7%	21
2024 Q2	$27.6M	Buy	3,675,077 +1,500,000	+69%	+$13.1M	0.93%	19
2024 Q1	$21.7M	Buy	2,175,077 +300,000	+16%	+$3.34M	0.91%	19
2023 Q4	$18.5M	Buy	1,875,077 +1,100,000	+142%	+$7.84M	0.89%	19
2023 Q3	$5.93M	Hold	775,077	–	–	0.32%	26
2023 Q2	$5.79M	Buy	+775,077	New	+$5.42M	0.37%	26